Position in INSM
as of Jun 30, 2026
· filed Jul 9, 2026
Position Value
$498,128
New position
Shares Held
4,672
first reported quarter
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#405
of 663 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Biotechnology
Healthcare · as of Jun 30, 2026Wealthcare Advisory Partners LLC holds $3,930,359 across 8 Biotechnology names. INSM ranks #2 (12.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,627 | $2,298,369 | |
| 2 | INSM |
INSMED Inc
This page
|
4,672 | $498,128 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,280 | $385,318 | |
| 4 | ERAS |
Erasca, Inc.
|
15,924 | $291,727 | |
| 5 | EXEL |
Exelixis, Inc.
|
3,852 | $209,587 | |
| 6 | CMPX |
Compass Therapeutics, Inc.
|
60,962 | $133,506 | |
| 7 | NRXS |
Neuraxis, INC
|
15,188 | $111,024 | |
| 8 | IGC |
IGC Pharma, Inc.
|
10,000 | $2,700 |
All Filings in INSM
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $498,128 | 4,672 | Shares | Sole | 2026-07-09 | |
| No filing history on record for this holder in this stock. | ||||||